Boehringer Ingelheim and BioMed X have formed a new research team to conduct research to identify novel approaches for the treatment of patients with psychiatric diseases. The members of this team had submitted the most promising solution approaches in a crowdsourcing competition. According to the World Health Organization (WHO), mental illness, together with substance abuse disorders, remains the leading cause of disability worldwide. At least 450 million people suffer from mental health pro...